2025-04-15 - Analysis Report
## Air Products and Chemicals Inc. (APD) Stock Report

**0. Executive Summary:**

Air Products and Chemicals Inc. (APD) is a leading industrial gases company.  While APD's cumulative return (26.86%) significantly lags the S&P 500's (66.69%), its financial performance shows some resilience despite recent market headwinds.  Further analysis reveals mixed signals, requiring a careful consideration of both short-term volatility and long-term growth potential.


**1. Performance Comparison:**

Air Products and Chemicals Inc. (APD) is a leading industrial gases company providing atmospheric, process, and specialty gases.

* **Cumulative Return (APD):** 26.86%
* **Cumulative Return (VOO - S&P 500):** 66.69%
* **Return Difference:** -39.8%
* **Relative Lag (based on historical range):** 22.9% (This means APD's underperformance relative to the S&P 500 is at the 22.9th percentile of its historical range of under/outperformance)


**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 23.0% | 53.7% | -6.0% | 0.1 | 30.7 |
| 2016-2018  | 22.0% | 62.1% | 5.0% | 0.4 | 30.7 |
| 2017-2019  | 50.0% | 62.1% | 21.0% | 0.8 | 46.1 |
| 2018-2020  | 36.0% | 62.1% | 10.0% | 0.6 | 54.8 |
| 2019-2021  | 59.0% | 59.2% | 5.0% | 0.6 | 62.3 |
| 2020-2022  | 22.0% | 71.4% | 16.0% | 0.6 | 64.8 |
| 2021-2023  | -18.0% | 71.4% | 0.8 | -35.0% | 59.0 |
| 2022-2024  | -26.0% | 71.4% | 0.8 | -43.0% | 63.7 |
| 2023-2025  | -57.0% | 74.6% | 1.2 | -71.0% | 60.6 |

The data shows significant variability in CAGR and Alpha, indicating fluctuating performance relative to the market (Beta).  The negative CAGRs in recent years are concerning.


**2. Recent Price Movement:**

* **Closing Price:** $272.58
* **5-Day Moving Average:** $264.49
* **20-Day Moving Average:** $281.67
* **60-Day Moving Average:** $303.04

The price is below all three moving averages, suggesting a bearish short-term trend.  The recent price increase of $1.33 (Last-market data) signals a potential short-term bounce, but the overall trend remains weak.


**3. Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4585 (High Risk)
* **RSI:** 40.22 (Approaching oversold territory, but not yet definitively so)
* **PPO:** -0.3734 (Negative, indicating bearish momentum)
* **20-Day Relative Divergence Change:** -5.4% (Short-term bearish trend)
* **Expected Return (vs. S&P 500, long-term):** -30.5%  This suggests a significant underperformance relative to the S&P 500 over the long term, based on current projections.  The recent price increase needs to be considered within this projection.


**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue     |
|------------|-------|-------------|
| 2025-02-06 | 2.77  | $2.93 B     |
| 2024-08-01 | 3.13  | $2.99 B     |
| 2024-04-30 | 2.57  | $2.93 B     |
| 2024-02-05 | 2.74  | $3.00 B     |
| 2025-02-06 | 2.74  | $3.00 B     | *(Duplicate data point, likely an error)*

Earnings show some fluctuation.  Revenue remains relatively consistent, but EPS shows variability.  The duplicate entry needs clarification.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $2.93B | 31.21% |
| 2024-09-30 | $3.19B | 33.98% |
| 2024-06-30 | $2.99B | 32.82% |
| 2024-03-31 | $2.93B | 32.04% |
| 2023-12-31 | $3.00B | 31.03% |

Revenue is relatively stable, with profit margins consistently above 30%, indicating healthy profitability.

**Capital and Profitability:**

| Quarter | Equity    | ROE      |
|---------|-----------|----------|
| 2024-12-31 | $16.69B  | 3.70%   |
| 2024-09-30 | $17.04B  | 11.45%  |
| 2024-06-30 | $15.10B  | 4.61%   |
| 2024-03-31 | $14.91B  | 3.84%   |
| 2023-12-31 | $14.87B  | 4.10%   |

Equity fluctuates but ROE shows some variability, reaching a high of 11.45% in Q3 2024.


**6. Overall Analysis:**

APD's performance shows a mixed picture. While the company demonstrates consistent revenue and healthy profit margins, its stock price has significantly underperformed the S&P 500 recently. Technical indicators suggest a bearish short-term outlook, further reinforced by the negative long-term expected return relative to the market.  However, fundamental financial health appears reasonably sound.  A deeper dive into the causes for the recent negative CAGR and the inconsistencies in the provided data (duplicate earnings data point) is needed for a more conclusive assessment.  Investors should carefully consider these factors alongside their own risk tolerance and investment horizon before making any decisions.  The negative projected long-term return (-30.5%) is a significant concern and should be carefully evaluated against potential future growth catalysts for the company.
